Elemental Impurity Analysis in Pharmaceuticals: Validating performance of an Agilent 7800 ICP MS
Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. To…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
West Launches AccelTRA® RTS/RTU Product Line in India
The AccelTRA components program was designed to provide generic drug manufacturers with components for injectable drug delivery…
Inovio gets $71 million from US defense department for COVID-19 vaccine device
Inovio, which began human testing of its vaccine in April, said it expects to report interim results from the trial later this…
Industry should come forward to develop Pharma and Medical Devices parks: Mansukh Mandaviya
He made the statement while addressing the launch webinar of India’s first virtual exhibition and conference, ‘Virtual Healthcare…
Trials with Oxford COVID-19 vaccine start in Brazil
Trials will count on 2,000 health workers volunteers in Sao Paulo and 1,000 people in Rio de Janeiro
Gilead to commence trials of inhaled remdesivir
The CEO informs that the company aims to enable easier administration outside the hospital at earlier stages of the disease with…
Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine
In the recent past, many, globally and in India, had raised concerns about a potential shortage of ancillary supplies to…
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be…
G1 Therapeutics and Genor Biopharma sign agreement for Lerociclib
As per the exclusive license agreement, Genor to lead clinical development, regulatory submissions and commercialisation of…
Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20
Consolidated Profit before Tax (PBT) recorded extraordinary growth by 34 per cent at Rs. 39.11 crore, up from Rs. 29.18 crore in…